HVO: Record orderbook and CRS Berlin acquisition drive strong outlook despite H1 revenue dip

Revenue for H1 2026 declined to £16.3m due to timing shifts, but a record £72m orderbook and the CRS Berlin acquisition position the group for strong H2 and future growth. Laboratory revenue surged 110% year-over-year, and FY 2026 revenue guidance is £47m.Original document: hVIVO plc [HVO] Slides R…